Objective: To characterize decorin and chondroitin sulfate (CS) expression in lichen sclerosus (LS).

Study Design: Thirty-one untreated vulvar LS lesions were biopsed, and hematoxylin-eosin-stained cases were graded according to Hewitt's classification. Immunohistochemistry was performed using antibodies directed against human decorin diluted 1:500 and CS diluted 1:200. The control group, made up of cutaneous fragments from vulvoperineal corrective surgeries or nymphoplasties, represented 22 patients.

Results: Decorin and CS were present at the LS hyaline zone in different moments of matrix modulation. In all Hewitt stages CS prevailed at the extracellular matrix in cases with a compact aspect of the hyaline zone, while decorin was seen only in areas of less compactness. Normal vulvar tissue revealed only the presence of CS in juxtaepithelial zones. No decorin immunoexpression was found in normal vulvar skin.

Conclusion: Decorin and CS deposition in vulvar LS varies in the distinct histologic stages, which probably reflect the importance of these molecules in matricial remodeling in this disorder. Decorin may play an important role in cases of LS.

Download full-text PDF

Source

Publication Analysis

Top Keywords

decorin
8
decorin chondroitin
8
chondroitin sulfate
8
lichen sclerosus
8
hyaline zone
8
normal vulvar
8
vulvar
5
sulfate distribution
4
distribution vulvar
4
vulvar lichen
4

Similar Publications

Background: In response to exercise-based pulmonary rehabilitation (PR), the type of muscle fibre remodelling differs between COPD patients with peripheral muscle wasting (atrophic patients with COPD) and those without wasting (nonatrophic patients with COPD). Extracellular matrix (ECM) proteins are major constituents of the cell micro-environment steering cell behaviour and regeneration. We investigated whether the composition of ECM in atrophic compared to nonatrophic patients with COPD differs in response to PR.

View Article and Find Full Text PDF

Inhibition of chondroitin sulphate-degrading enzyme Chondroitinase ABC by dextran sulphate.

Glycoconj J

January 2025

School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW, 2109, Australia.

Chondroitin sulphate (CS) is a sulphated glycosaminoglycan (GAG) polysaccharide found on proteoglycans (CSPGs) in extracellular and pericellular matrices. Chondroitinase ABC (CSase ABC) derived from Proteus vulgaris is an enzyme that has gained attention for the capacity to cleave chondroitin sulphate (CS) glycosaminoglycans (GAG) from various proteoglycans such as Aggrecan, Neurocan, Decorin etc. The substrate specificity of CSase ABC is well-known for targeting various structural motifs of CS chains and has gained popularity in the field of neuro-regeneration by selective degradation of CS GAG chains.

View Article and Find Full Text PDF

Sex Differences in Aortic Valve Inflammation and Remodeling in Chronic Severe Aortic Regurgitation.

Am J Physiol Heart Circ Physiol

January 2025

Cardiovascular Translational Research. Navarrabiomed (Fundación Miguel Servet), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.

Aortic regurgitation (AR) is more prevalent in male, although cellular and molecular mechanisms underlying the sex differences in prevalence and pathophysiology are unknown. This study evaluates the impact of sex on aortic valve (AV) inflammation and remodeling as well as the cellular differences in valvular interstitial cells (VICs) and valvular endothelial cells (VECs) in patients with AR. A total of 144 patients (27.

View Article and Find Full Text PDF

Osseointegration is essential for successful implant treatment. However, the underlying molecular mechanisms remain unclear. In this study, we focused on decorin (DCN), which was hypothesized to be present in the proteoglycan (PG) layer at the interface between bone and the titanium oxide (TiOx) surface.

View Article and Find Full Text PDF

A novel patient group with chronic pulmonary fibrosis is emerging post COVID-19. To identify patients at risk of developing post-COVID-19 lung fibrosis, we here aimed to identify systemic proteins that overlap with fibrotic markers identified in patients with idiopathic pulmonary fibrosis (IPF) and may predict COVID-19-induced lung fibrosis. Ninety-two proteins were measured in plasma samples from hospitalized patients with moderate and severe COVID-19 in Sweden, before the introduction of the vaccination program, as well as from healthy individuals.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!